Industry Experts

Vinod Vathipadiekal is Chief Scientific Officer at ProGenis Pharmaceutical and a leader in oligonucleotide therapeutics, with extensive experience advancing RNA programs from discovery to early clinical development. He has held senior research and platform leadership roles across biotech and pharmaceutical organizations. Most recently, he served as CSO of Genetic Medicines at Alloy Therapeutics, where he built and led the AntiClastic ASO platform and established major pharma partnerships. He previously held leadership roles at Leal Therapeutics (VP, Head of Nucleic Acid Therapeutics) and Eisai (Director, Head of ASO Therapeutics).